Esquire Financial Holdings, Inc. filings document the public-company record for a Maryland financial holding company whose common stock trades on Nasdaq under ESQ and whose bank subsidiary is Esquire Bank, National Association.
The filing record includes Form 8-K disclosures for earnings releases, Regulation FD presentations, regular dividend actions, material agreements, and director or committee changes. Proxy materials cover annual-meeting governance, director matters, executive compensation, equity awards, pay-versus-performance data, and shareholder voting matters. The disclosures also identify the company's capital structure, banking subsidiary, Nasdaq-listed common stock, and governance framework.
Esquire Financial Holdings, Inc. director Caronia Leonard reports a holding in Common Stock with direct ownership of 0.0000 shares following the reported entry dated August 1, 2026. The report records one holding entry and shows no buy or sell transactions in company shares.
Esquire Financial Holdings, Inc. filed an initial statement of beneficial ownership for Michael G. O'Rourke, who serves as a director and as President of Chicago Bank Div. The filing reports Common Stock with 0.0000 shares held directly following the reported position entry.
Esquire Financial Holdings, Inc. director Robert Mitzman reported a sale of 3,000 shares of common stock on July 30, 2026 in a transaction coded as a sale in an open market or private transaction at $129.5973 per share. Following this sale, he directly holds 139,679 shares of common stock, which include multiple grants of restricted stock that vest between December 2024 and December 2027. He also holds 2,500 shares indirectly through an insurance trust I and 2,500 shares indirectly through an insurance trust II.
Esquire Financial Holdings, Inc. completed its previously announced merger with Signature Bancorporation, Inc. on August 1, 2026. A merger subsidiary first combined with Signature, which then merged into Esquire, followed by the merger of Signature Bank into Esquire Bank, National Association, with Esquire Bank as the surviving bank.
Each share of Signature common stock was converted into the right to receive 2.671 shares of Esquire common stock, with cash paid in lieu of fractional shares. Outstanding Signature stock options (other than those granted after March 11, 2026) fully vested, were assumed by Esquire, and adjusted by the Exchange Ratio for both shares and exercise price while retaining their prior terms.
Esquire’s board was increased to ten directors, adding former Signature leaders Michael G. O’Rourke and Leonard S. Caronia, who are expected to serve through the 2027 annual meeting, subject to stockholder election. O’Rourke became President of Signature, a division of Esquire Bank, under an employment agreement, and he and certain former Signature executives are subject to a lock-up restricting sales of Esquire shares received in the merger. Esquire plans to file acquired-business financial statements and pro forma financial information by amendment within 71 days of the required filing date.
Esquire Financial Holdings, Inc., the financial holding company for Esquire Bank, declared a regular quarterly cash dividend of $0.20 per share of common stock. The dividend is payable on September 1, 2026 to stockholders of record as of August 14, 2026.
Esquire Financial is headquartered in Jericho, New York. Its wholly owned subsidiary, Esquire Bank, operates as a full-service commercial bank focused on serving the litigation industry and small businesses nationally, along with commercial and retail customers in the New York and Los Angeles metropolitan areas.
Esquire Financial Holdings, Inc. reported Q2 2026 net income of $13.0 million, or $1.49 diluted EPS, versus $11.9 million, or $1.38, in Q2 2025. Year-to-date net income was $25.2 million, or $2.89 diluted EPS. Returns on average assets and equity were 2.09% and 17.06% for the quarter.
Net interest income rose to $35.7 million on 23.5% growth in average interest-earning assets to $2.40 billion, while net interest margin was 5.96%. Average loans increased 28.3% to $1.88 billion, led by litigation-related lending, and average deposits grew 23.6% to $2.16 billion; the loan-to-deposit ratio was 87% at June 30, 2026.
The provision for credit losses was $2.9 million in Q2, and nonperforming loans totaled $5.1 million, with an allowance equal to 1.30% of total loans. Noninterest expense increased to $21.1 million, including $1.1 million of Signature merger costs, producing an efficiency ratio of 50.1% (47.6% adjusted). Total assets reached $2.51 billion, deposits $2.18 billion, and stockholders’ equity $313.9 million, with capital ratios above regulatory “well capitalized” levels. Management highlighted the pending merger with Signature, currently scheduled to close on August 1, 2026, and furnished an investor presentation alongside these results.
Esquire Financial Holdings reported that its stockholders approved the issuance of Esquire common stock to holders of Signature Bancorporation, Inc. common stock in connection with the proposed merger. The vote passed at a special meeting where 6,586,054 shares were represented, constituting a quorum.
The meeting used an April 29, 2026 record date with 8,639,431 shares outstanding as of that date. The company and Signature issued joint press releases announcing the final exchange ratio and the meeting results.
Esquire Financial Holdings, Inc. reported that its stockholders approved issuing new Esquire common shares to Signature Bancorporation shareholders for their planned merger. At the April 29, 2026 record date, Esquire had 8,639,431 shares outstanding, and 6,586,054 shares were represented at the June 23 special meeting, constituting a quorum.
The share issuance proposal passed with 6,568,618 votes for, 9,444 against and 7,992 abstentions. Based on Signature’s sale of approximately $70 million of Schedule A Loans at a roughly 62.0% recovery rate, the final exchange ratio was set at 2.671 Esquire shares per Signature share, up from the previously assumed 2.630.
This change raises the expected Esquire shares issued to Signature holders from 3.393 million to 3.447 million, an increase of about 54 thousand shares, or 1.6%. All required regulatory and stockholder approvals have been received, and the companies anticipate closing the merger in the third quarter of 2026, subject to remaining customary conditions.
Esquire Financial Holdings, Inc. and Signature Bancorporation, Inc. issued a joint press release on June 9, 2026 announcing receipt of all regulatory approvals related to the merger of Signature with and into Esquire. The filing states a registration statement on Form S-4 has been filed and a joint proxy statement/prospectus was mailed on May 11, 2026 seeking required shareholder approvals. The press release is filed as Exhibit 99.1 and is incorporated by reference. The report includes customary forward-looking statements and directs readers to the Form S-4 and joint proxy statement/prospectus for detailed terms and risks.
Esquire Financial Holdings, Inc. and Signature Bancorporation, Inc. have received all required regulatory approvals and waivers for their proposed merger. Approvals include a waiver of prior approval for the holding company merger from the Federal Reserve Bank of New York and approval of the bank merger from the Office of the Comptroller of the Currency.
The transaction is not yet complete. Closing of the merger remains subject to approvals from Esquire stockholders and Signature shareholders, along with certain other customary closing conditions. Both companies reiterate typical forward-looking statement cautions and direct investors to the Form S-4 registration statement and joint proxy statement/prospectus for detailed information about the proposed deal.